UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Endometrial carcinoma: molecular alterations involved in tumor development and progression

Oncogene, 2013-01, Vol.32 (4), p.403-413

2013

Volltextzugriff (PDF)

CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells

Oncogene, 2008-04, Vol.27 (18), p.2513-2524

2008

Volltextzugriff (PDF)

The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms

European journal of cancer (1990), 2010-03, Vol.46 (4), p.836-850

2010

Volltextzugriff (PDF)

Oxidative stress‐induced FAK activation contributes to uterine serous carcinoma aggressiveness

Molecular oncology, 2023-01, Vol.17 (1), p.98-118

2023

Volltextzugriff (PDF)

Endometrial Carcinoma: Specific Targeted Pathways

Advances in experimental medicine and biology, 2017, Vol.943, p.149-207

2017

Volltextzugriff (PDF)

Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

Cancers, 2022-06, Vol.14 (12), p.2842

2022

Volltextzugriff (PDF)

Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (13), p.3702-3710

2016

Volltextzugriff (PDF)

Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells

Molecular oncology, 2012-10, Vol.6 (5), p.530-541

2012

Volltextzugriff (PDF)

Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition

British journal of cancer, 2016-10, Vol.115 (8), p.929-939

2016

Volltextzugriff (PDF)

Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism

Oncotarget, 2016-08, Vol.7 (32), p.52364-52374

2016

Volltextzugriff (PDF)

Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway

International journal of cancer, 2012-02, Vol.130 (4), p.967-978

2012

Volltextzugriff (PDF)

2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels

Pigment cell and melanoma research, 2016-05, Vol.29 (3), p.352-371

2016

Volltextzugriff (PDF)

Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells

Molecular oncology, 2013-08, Vol.7 (4), p.763-775

2013

Volltextzugriff (PDF)

Antioxidants block proteasome inhibitor function in endometrial carcinoma cells

Anti-cancer drugs, 2008-02, Vol.19 (2), p.115-124

2008

Volltextzugriff (PDF)

N‐ras gene activation in the rd human rhabdomyosarcoma cell line

International journal of cancer, 1985-05, Vol.35 (5), p.647-652

1985

Volltextzugriff (PDF)

Cellular and molecular mechanisms of antiretroviral effects of HPA23

Cancer detection and prevention, 1988, Vol.12 (1-6), p.181

1988

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(16)

Sprache

Englisch
(16)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(14)
Female
(9)
Tumors
(8)
Apoptosis
(7)
Cell Line, Tumor
(7)
Antineoplastic Agents - Pharmacology
(6)
Carcinoma
(6)
Endometrial Cancer
(6)
Endometrial Neoplasms - Metabolism
(6)
Endometrium
(6)
Apoptosis - Drug Effects
(5)
Cancer
(5)
Endometrial Carcinoma
(5)
Endometrial Neoplasms - Pathology
(5)
Mutation
(5)
Uterine Cancer
(5)
Animals
(4)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Endometrial carcinoma: molecular alterations involved in tumor development and progression

CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells

The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms

Oxidative stress‐induced FAK activation contributes to uterine serous carcinoma aggressiveness

Endometrial Carcinoma: Specific Targeted Pathways

Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer

Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain

Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells

Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition

Metabotyping human endometrioid endometrial adenocarcinoma reveals an implication of endocannabinoid metabolism

Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway

2-phenylethynesulphonamide (PFT-μ) enhances the anticancer effect of the novel hsp90 inhibitor NVP-AUY922 in melanoma, by reducing GSH levels

Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells

Antioxidants block proteasome inhibitor function in endometrial carcinoma cells

N‐ras gene activation in the rd human rhabdomyosarcoma cell line

Cellular and molecular mechanisms of antiretroviral effects of HPA23

Aktive Filter

Suchergebnisse filtern